Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Glenn R. Mattes currently holds 36,000 shares of Arno Therapeutics, Inc (ARNI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Glenn R. Mattes has been a net seller of ARNI stock. They have purchased $297.5K and sold $4.4M worth of shares.
Glenn R. Mattes's most recent insider trade was on May 16, 2022, when they purchased 16,000 shares at $4.78 per share.
Glenn R. Mattes serves as Executive at Arno Therapeutics, Inc (ARNI). They have executed 22 insider transactions totaling $4.7M over their tenure at the company.
Glenn R. Mattes holds the position of Executive at Arno Therapeutics, Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Glenn R. Mattes has shown a selling trading pattern, with $297.5K in total purchases and $4.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Glenn R. Mattes was on Nov 10, 2020, when they sold $1.6M worth of TFFP shares. This transaction involved 108,830 shares at $15.00 per share.
Glenn R. Mattes currently owns 36,000 shares of Arno Therapeutics, Inc (ARNI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Glenn R. Mattes's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Glenn R. Mattes has 22 Form 4 filings on record as an insider at Arno Therapeutics, Inc.
Set alerts for Glenn R. Mattes and 40,000+ other insiders.